Bank of Marin Bancorp — Q1 2021 Form 10-Q
Reporting period: Three months ended March 31, 2021; balance-sheet comparisons are to December 31, 2020 unless stated otherwise. Unaudited consolidated results cover Bancorp and Bank of Marin.
Financial performance
| Metric | Q1 2021 | Comparable period / change |
|---|---|---|
| Net interest income | $22.0 million | $24.1 million in Q1 2020, down $2.1 million |
| Non-interest income | $1.8 million | $3.1 million in Q1 2020, down 41.5% |
| Net income | $8.9 million | $7.2 million in Q1 2020 |
| Diluted EPS | $0.66 | $0.53 in Q1 2020 |
| Tax-equivalent net interest margin | 3.19% | 3.88% in Q1 2020 |
| Efficiency ratio | 62.13% | 56.79% in Q1 2020; 58.92% excluding accelerated debenture discount accretion |
| Return on average assets / equity | 1.21% / 10.22% | 1.09% / 8.54% in Q1 2020 |
| Operating cash flow | $12.4 million provided | $9.5 million provided in Q1 2020 |
Net interest income was pressured by the low-rate environment, lower yields, and $1.3 million of accelerated discount accretion following early redemption of the subordinated debenture. Lower interest expense on deposits and PPP loan fees partly offset these factors. Non-interest income fell largely because Q1 2020 included an $800,000 securities-sale gain; service charges and other income also declined. Non-interest expense was $14.8 million, down 4.2% year over year, including a $590,000 reversal of the allowance for unfunded commitments.
Financial position, credit and liquidity
- Total assets were $3.06 billion; deposits were $2.66 billion, up $152.0 million during the quarter. Non-interest-bearing deposits were $1.45 billion, or 54.4% of deposits.
- Loans totaled $2.12 billion, up $33.2 million. The increase reflected $73.4 million net growth in PPP loans, partly offset by a $40.2 million decline in non-PPP loans. PPP balances were $365.0 million across 2,513 loans.
- Investment securities totaled $670.5 million, up $169.2 million. Cash and cash equivalents were $142.8 million, down from $200.3 million, as the company redeployed liquidity into securities and loans.
- Allowance for loan losses was $20.0 million, or 0.94% of loans (1.14% excluding SBA-guaranteed PPP loans), versus 1.10% (1.27% excluding PPP) at year-end. The quarter included a $2.9 million loan-loss provision reversal, attributed primarily to improved California unemployment forecasts and lower non-PPP balances.
- Non-accrual loans were $9.2 million, or 0.43% of loans, broadly unchanged from year-end. Special Mention loans declined to $56.0 million from $86.9 million; classified loans were $26.4 million. No loan charge-offs were reported in Q1.
- At March 31, 13 borrower relationships with 20 loans totaling $65.4 million remained in payment relief; the filing reported $56.1 million across 10 relationships as of May 4. Management said it expected most to resume payments as the economy reopened.
- Operating cash flow of $12.4 million was more than offset by $205.8 million of investing outflows, primarily securities purchases, and partly funded by $135.8 million of financing inflows, including deposit growth. Cash declined $57.5 million over the quarter.
- No borrowings were outstanding under the disclosed correspondent, FHLB, or Federal Reserve lines. Available capacity included $634.2 million in FHLB lines and $77.5 million under the Federal Reserve line, subject to collateral and terms. Total unfunded commitments and standby letters were $610.8 million.
- Bancorp’s total risk-based capital ratio was 15.68%; the Bank’s was 14.78%. Both were above well-capitalized regulatory thresholds. Bancorp’s tangible common equity to tangible assets was 10.47%, down from 11.27% at year-end.
Material changes, outlook and risks
- On March 15, Bancorp redeemed its last subordinated debenture, with a $2.8 million book value and an approximately 5.7% effective rate. Accelerated accretion generated $1.3 million of Q1 interest expense; management said the redemption should improve future net interest margin.
- On April 16, after quarter-end, Bancorp agreed to acquire American River Bankshares in a stock transaction at a fixed exchange ratio of 0.575 Bancorp shares per AMRB share. The filing valued the transaction at approximately $134.5 million based on Bancorp’s April 16 share price; closing was expected in Q3 2021, subject to shareholder, regulatory and other approvals. Management expected the deal to be earnings-accretive, but this is forward-looking and not assured.
- Management said strong liquidity, capital, credit quality and a low-cost deposit base should help the company navigate the low-rate environment. It expected net interest margin to improve in Q2 as PPP loan forgiveness accelerates. No quantified full-year earnings or financial guidance was provided.
- Key risks include persistently low rates, deposit fluctuations, borrower performance as COVID-related payment relief ends, real-estate and economic conditions, acquisition integration and approval, and operational, regulatory, cybersecurity and natural-disaster risks. Interest-rate simulations estimated year-one net interest income increases of 1.8% to 8.9% for parallel rate rises of 100 to 400 basis points and a 1.2% decline for a 100-basis-point decrease; management cautioned that model assumptions limit the predictive value.
- The company reported no material change in previously disclosed risk factors and no pending legal proceeding expected to have a material adverse effect. Visa-related litigation remains unresolved; management considered a loss remote and reported no required future cash settlement while the relevant escrow remains available.
Important facts for investors to verify
- Whether PPP forgiveness and fee recognition support the anticipated Q2 margin improvement, and how much loan growth remains after excluding PPP.
- Whether loans in payment relief resume contractual payments and whether credit quality, the allowance and non-accrual levels remain stable.
- Deposit concentration and volatility, liquidity available against $610.8 million of commitments, and the sustainability of funding costs.
- Actual acquisition approvals, closing timing, share issuance, integration costs, realized synergies and earnings impact versus management’s accretion expectation.
- Future earnings and capital effects of share repurchases, dividends, securities valuation changes and the debenture redemption.